Chung Hang J Choi

Title: Innovations in Nucleic Acid Delivery by Chung Hang J Choi

Introduction

Chung Hang J Choi is a prominent inventor based in Evanston, IL (US). He has made significant contributions to the field of nucleic acid delivery through his innovative research and patents. His work focuses on enhancing the effectiveness of therapeutic delivery systems, particularly using spherical nucleic acids.

Latest Patents

Choi holds a patent titled "Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates." This patent addresses the challenges associated with nucleic acid delivery. The research demonstrates that G-rich spherical nucleic acids (SNAs) exhibit several-fold higher uptake into cells compared to SNAs rich in other nucleotides. This advancement provides an effective strategy to maximize the intracellular delivery of SNAs, which can be applied to various nanoparticle systems. It establishes an important design consideration for the intracellular delivery of therapeutics.

Career Highlights

Choi is affiliated with Northwestern University, where he continues to advance his research in the field of nanotechnology and nucleic acid delivery. His work has garnered attention for its potential applications in medical therapeutics and drug delivery systems.

Collaborations

Choi has collaborated with notable researchers, including Chad A Mirkin and Suguna P Narayan. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Chung Hang J Choi's contributions to the field of nucleic acid delivery through his patent and research at Northwestern University highlight the importance of innovation in therapeutic applications. His work continues to pave the way for advancements in nanoparticle-based drug delivery systems.